Associated Papers
Cytochrome P450 2A6 whole-gene deletion (CYP2A6*4) polymorphism reduces risk of lung cancer: A meta-analysis.
Johani FH et al.
Tobacco Induced Diseases, 2020
Genetic Polymorphisms of CYP2A6 in a Case-Control Study on Bladder Cancer in Japanese Smokers.
Kumondai M et al.
Biological & Pharmaceutical Bulletin, 2016
CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.
Hosono H et al.
Drug Metabolism and Pharmacokinetics, 2015
Direct sequencing and comprehensive screening of genetic polymorphisms on CYP2 family genes (CYP2A6, CYP2B6, CYP2C8, and CYP2E1) in five ethnic populations.
Kim JH et al.
Archives of Pharmacal Research, 2015
Three haplotypes associated with CYP2A6 phenotypes in Caucasians.
Haberl M et al.
Pharmacogenetics and Genomics, 2005
Select a paper to view details